Published in TB and Outbreaks Week, April 3rd, 2001
J. Aristegui and colleagues evaluated the safety profiles of the two vaccine delivery approaches in 18-month-old children previously given three doses of DTPw and Hib vaccines.
"Children were randomized to receive DTPa/Hib (group 1; n=111) or DTPw + Hib (group 2; n=105) and were followed for up to 30 days...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.